LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1365

Search options

  1. Article ; Online: Preparation and Hemocompatibility of Novel Antioxidant-Modified Polyethersulfone Membranes as Red Blood Cell Thrombosis Inhibitors.

    Fu, Xiao / Lei, Ting / Song, Shitao / Xia, Luling / Xiao, Yuan / Xiao, Gong

    Macromolecular bioscience

    2024  , Page(s) e2300496

    Abstract: The contact between the dialysis membrane and blood can induce oxidative stress and thrombosis, causing oxidative organ damage and impaired toxin clearance. To date, the selection of anticoagulants has focused on mechanisms inhibiting white, but not red ( ...

    Abstract The contact between the dialysis membrane and blood can induce oxidative stress and thrombosis, causing oxidative organ damage and impaired toxin clearance. To date, the selection of anticoagulants has focused on mechanisms inhibiting white, but not red (erythrocytes) thrombus formation. In the present study, polyethersulfone (PES) membranes are modified with the antioxidant drug tiopronin; the physicochemical properties and dialysis performance of the Tio-PES membranes are evaluated. The effects on erythrocyte thrombosis are evaluated in terms of erythrocyte morphology, prothrombotic properties (adhesion, aggregation, viscosity, sedimentation, and hemolysis), and fibrinogen (FIB)-erythrocyte interactions. The regular anticoagulant and antiplatelet properties are also assessed. Superoxide dismutase, malondialdehyde, plasma protein, and complement C3a are further determined. Finally, the biosafety of the Tio-PES membranes is evaluated both in vitro and in vivo. The Tio-PES membranes exhibit excellent physicochemical properties and improved dialysis performance. It is found that the Tio-PES membranes stabilize erythrocyte morphology, reduce erythrocyte prothrombotic properties, decrease FIB adsorption, and prevent red thrombus formation. In addition, the Tio-PES membranes exhibit excellent antioxidant properties and show biosafety in primary toxicity studies. Thus, Tio-PES membranes hold promise as novel, safe, and effective dialysis materials for potential clinical application.
    Language English
    Publishing date 2024-02-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2039130-4
    ISSN 1616-5195 ; 1616-5187
    ISSN (online) 1616-5195
    ISSN 1616-5187
    DOI 10.1002/mabi.202300496
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research.

    Gong, Fa-Min / Liu, Fu-Yue / Ma, Xue / Ma, Song-Tao / Xiao, Hong-Tao / Jiang, Gang / Qi, Ting-Ting

    Frontiers in pharmacology

    2024  Volume 15, Page(s) 1288964

    Abstract: Objective: ...

    Abstract Objective:
    Language English
    Publishing date 2024-01-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2024.1288964
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Construction and study of blood purification membrane modified with PDE inhibitor: Investigation of antiplatelet activity and hemocompatibility.

    Fu, Xiao / Lei, Ting / Chen, Cong / Fu, Gan

    Colloids and surfaces. B, Biointerfaces

    2023  Volume 234, Page(s) 113725

    Abstract: The recent "cell-based theory" of coagulation suggests that platelets serve as the site of coagulation factor reactions, making platelets an effective target for inhibiting membrane thrombosis. Unfortunately, there is limited research on how blood ... ...

    Abstract The recent "cell-based theory" of coagulation suggests that platelets serve as the site of coagulation factor reactions, making platelets an effective target for inhibiting membrane thrombosis. Unfortunately, there is limited research on how blood purification membranes affect platelet intracellular signaling. In this study, we modified polyethersulfone (PES) membranes with the platelet phosphodiesterase (PDE) inhibitor dipyridamole (DIP) and investigated the effects of the DIP/PES (DP) membranes on platelet adhesion, activation, aggregation, and secretion, as well as the role of the PDE-cyclic adenosine monophosphate (cAMP) intracellular signaling pathway. Additionally, we evaluated the hemocompatibility and preliminary in vivo safety of DP membranes. Our results demonstrate that the modified DP membranes effectively inhibited platelet adhesion, membrane CD62P expression, and plasma soluble P-selectin activation levels. Furthermore, we confirmed that DP membranes achieved platelet aggregation inhibition and reduced platelet factor 4 and β-thromoglobulin secretion levels by inhibiting platelet intracellular PDE-cAMP signaling. Moreover, the modified DP membranes exhibited good anticoagulant and red blood cell membrane stability and complement resistance and demonstrated preliminary biocompatibility in mouse experiments. Collectively, these findings highlight the potential application of DP dialysis membranes in blood purification for critically ill patients.
    MeSH term(s) Humans ; Mice ; Animals ; Phosphodiesterase Inhibitors/pharmacology ; Phosphodiesterase Inhibitors/metabolism ; Renal Dialysis ; Platelet Aggregation Inhibitors/pharmacology ; Dipyridamole/metabolism ; Dipyridamole/pharmacology ; Blood Platelets ; Platelet Aggregation
    Chemical Substances Phosphodiesterase Inhibitors ; Platelet Aggregation Inhibitors ; Dipyridamole (64ALC7F90C)
    Language English
    Publishing date 2023-12-24
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1500523-9
    ISSN 1873-4367 ; 0927-7765
    ISSN (online) 1873-4367
    ISSN 0927-7765
    DOI 10.1016/j.colsurfb.2023.113725
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Preparation and blood compatibility of polyethersulfone dialysis membrane modified by apixaban as coagulation factor Xa inhibitor.

    Fu, Xiao / Lei, Ting / Xiao, Yuan / Tang, Ci

    Biomaterials advances

    2022  Volume 139, Page(s) 213012

    Abstract: Blood purification therapy is widely used in the treatment of critically ill patients. However, most dialysis membranes are prone to thrombosis. Activated coagulation factor X (FXa) functions at the intersection of intrinsic, extrinsic, and common ... ...

    Abstract Blood purification therapy is widely used in the treatment of critically ill patients. However, most dialysis membranes are prone to thrombosis. Activated coagulation factor X (FXa) functions at the intersection of intrinsic, extrinsic, and common coagulation pathways and plays a central role in thrombogenesis. To date, few dialysis membranes that directly inhibit FXa have been reported. We modified a polyethersulfone(PES) membrane using apixaban as an FXa inhibitor and investigated the performance of this membrane (AMPES). The contact angle of the modified membrane was reduced. PWF and retention rates of BSA were increased, demonstrating good hydrophilicity and dialysis performance. Albumin adsorption was reduced from 141.8 ± 15.5 to 114.1 ± 6.9 μg cm
    MeSH term(s) Animals ; Anticoagulants/pharmacology ; Antithrombin III ; Factor Xa/metabolism ; Factor Xa Inhibitors/pharmacology ; Fibrinolytic Agents/pharmacology ; Humans ; Membranes, Artificial ; Mice ; Polymers ; Pyrazoles ; Pyridones ; Renal Dialysis/instrumentation ; Sulfones ; Thrombosis/drug therapy
    Chemical Substances Anticoagulants ; Factor Xa Inhibitors ; Fibrinolytic Agents ; Membranes, Artificial ; Polymers ; Pyrazoles ; Pyridones ; Sulfones ; polyether sulfone (25667-42-9) ; apixaban (3Z9Y7UWC1J) ; Antithrombin III (9000-94-6) ; Factor Xa (EC 3.4.21.6)
    Language English
    Publishing date 2022-07-04
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2772-9508
    ISSN (online) 2772-9508
    DOI 10.1016/j.bioadv.2022.213012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: [Photo-Degradation Mechanism and Pathway for Tetracycline in Simulated Seawater Under Irradiation of Visible Light].

    Xu, Heng-Tao / Fu, Xiao-Hang / Feng, Wei-Hua / Wang, Ting

    Huan jing ke xue= Huanjing kexue

    2023  Volume 44, Issue 6, Page(s) 3260–3269

    Abstract: To explore the mechanism and pathway for pollutant degradation in seawater by heterogeneous photocatalysts, the degradation of tetracycline (TC) in pure water and simulated seawater with different mesoporous ... ...

    Abstract To explore the mechanism and pathway for pollutant degradation in seawater by heterogeneous photocatalysts, the degradation of tetracycline (TC) in pure water and simulated seawater with different mesoporous TiO
    Language Chinese
    Publishing date 2023-06-13
    Publishing country China
    Document type English Abstract ; Journal Article
    ISSN 0250-3301
    ISSN 0250-3301
    DOI 10.13227/j.hjkx.202206237
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Iatrogenic pneumopericardium after therapeutic pericardiocentesis for pericardial effusion: a case report.

    Zhu, Yang-Yang / Wang, Ting-Ting / Xu, Xiao-Na / Xu, Jing-Yue / Fu, Hua-Ying / Li, Guang-Ping / Liu, Tong / Liu, Chang-Le

    Journal of geriatric cardiology : JGC

    2023  Volume 20, Issue 6, Page(s) 479–482

    Language English
    Publishing date 2023-06-21
    Publishing country China
    Document type Journal Article
    ZDB-ID 2421391-3
    ISSN 1671-5411
    ISSN 1671-5411
    DOI 10.26599/1671-5411.2023.06.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Construction of an Antithrombotic and Anti-Inflammatory Polyethersulfone Membrane.

    Fu, Xiao / Lei, Ting / Tang, Ci / Peng, Jie

    Macromolecular bioscience

    2023  Volume 23, Issue 7, Page(s) e2200543

    Abstract: In addition to being the core factor in thrombosis, thrombin is involved in various inflammatory disease responses, but few studies have examined whether and how it is involved in membrane-related inflammation. In this study, the thrombin inhibitor ... ...

    Abstract In addition to being the core factor in thrombosis, thrombin is involved in various inflammatory disease responses, but few studies have examined whether and how it is involved in membrane-related inflammation. In this study, the thrombin inhibitor dabigatran is used to modify a polyethersulfone dialysis membrane. The modified membrane shows good hydrophilic properties and dialysis performance. It reduces the thrombin level in a targeted manner, thereby significantly inhibiting coagulation factor activation (based on the prothrombin time, international normalized ratio, activated partial thromboplastin time and thrombin time) and reducing the fibrinogen level and platelet adhesion. On thromboelastography, it shows excellent dynamic antithrombotic capacity. The modified membrane inhibited membrane-related inflammation by inhibiting the production of the inflammatory mediators C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1β (IL-1β) via the thrombin/complement C5a pathway. Moreover, it is found to be safe in an in vivo study. Thus, the dabigatran-modified polyethersulfone membrane may reduce dialysis-related complications through its dual antithrombotic and anti-inflammatory effects.
    MeSH term(s) Humans ; Dabigatran ; Thrombin/metabolism ; Fibrinolytic Agents/pharmacology ; Anti-Inflammatory Agents/pharmacology ; Inflammation/drug therapy
    Chemical Substances Dabigatran (I0VM4M70GC) ; Thrombin (EC 3.4.21.5) ; Fibrinolytic Agents ; polyether sulfone (25667-42-9) ; Anti-Inflammatory Agents
    Language English
    Publishing date 2023-05-03
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2039130-4
    ISSN 1616-5195 ; 1616-5187
    ISSN (online) 1616-5195
    ISSN 1616-5187
    DOI 10.1002/mabi.202200543
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Nursing Care of a Child With Delirium Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Case Report.

    Fu, Cong-Hui / Li, Yan / Zhang, Yu-Cai / Yang, Xiao-Ya / Liu, Ji / Ju, Min-Jie / Xu, Ting-Ting

    Critical care nurse

    2024  Volume 44, Issue 2, Page(s) 13–20

    Abstract: Introduction: Children receiving extracorporeal membrane oxygenation are prone to delirium. This case report describes the nursing care of a child with delirium who received venoarterial extracorporeal membrane oxygenation. Relevant interventions and ... ...

    Abstract Introduction: Children receiving extracorporeal membrane oxygenation are prone to delirium. This case report describes the nursing care of a child with delirium who received venoarterial extracorporeal membrane oxygenation. Relevant interventions and precautions are also discussed.
    Clinical findings: A 6-year-old girl was admitted to the pediatric intensive care unit with a 2-day history of vomiting and fever. The child underwent cannulation for venoarterial extracorporeal membrane oxygenation.
    Diagnosis: The child was diagnosed with acute fulminant myocarditis, cardiac shock, and ventricular arrhythmia.
    Interventions: On the third day of extracorporeal membrane oxygenation, bedside nurses began using the Cornell Assessment of Pediatric Delirium to assess the child for delirium symptoms. The team of physicians and nurses incorporated a nonpharmacologic delirium management bundle into pediatric daily care. Delirium screening, analgesia and sedation management, sleep promotion, and family participation were implemented.
    Outcomes: During the 18 days of pediatric intensive care unit hospitalization, the child had 6 days of delirium: 1.5 days of hypoactive delirium, 1.5 days of hyperactive delirium, and 3 days of mixed delirium. The child was successfully discharged home on hospital day 22.
    Conclusion: Caring for a child with delirium receiving venoarterial extracorporeal membrane oxygenation required multidimensional nursing capabilities to prevent and reduce delirium while ensuring safe extracorporeal membrane oxygenation. This report may assist critical care nurses caring for children under similar circumstances.
    MeSH term(s) Child ; Female ; Humans ; Arrhythmias, Cardiac ; Delirium/diagnosis ; Extracorporeal Membrane Oxygenation/methods ; Shock, Cardiogenic
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 632663-8
    ISSN 1940-8250 ; 0279-5442
    ISSN (online) 1940-8250
    ISSN 0279-5442
    DOI 10.4037/ccn2024150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The Role of Ranged Horses in Eco-Epidemiology of

    Chang, Qiao-Cheng / Hu, Yang / Wu, Ting-Ting / Ma, Xiao-Xiao / Jiang, Bao-Gui / Jia, Na / Wang, An-Qi / Jiang, Jia-Fu

    Frontiers in microbiology

    2022  Volume 12, Page(s) 795500

    Abstract: Rickettsia ... ...

    Abstract Rickettsia raoultii
    Language English
    Publishing date 2022-01-17
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587354-4
    ISSN 1664-302X
    ISSN 1664-302X
    DOI 10.3389/fmicb.2021.795500
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Human urinary cells for functional wound healing with sweat gland restoration.

    Ji, Shuai-Fei / Zhou, Lai-Xian / Li, Ying-Ying / Xiang, Jiang-Bing / Chen, Hua-Ting / Liu, Yi-Qiong / Fu, Xiao-Bing / Sun, Xiao-Yan

    Military Medical Research

    2023  Volume 10, Issue 1, Page(s) 57

    MeSH term(s) Humans ; Sweat Glands ; Wound Healing/physiology
    Language English
    Publishing date 2023-11-28
    Publishing country England
    Document type Letter
    ZDB-ID 2768940-2
    ISSN 2054-9369 ; 2054-9369
    ISSN (online) 2054-9369
    ISSN 2054-9369
    DOI 10.1186/s40779-023-00492-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top